Author:
Messager Mathieu,Mirabel Xavier,Tresch Emmanuelle,Paumier Amaury,Vendrely Véronique,Dahan Laetitia,Glehen Olivier,Vasseur Frederique,Lacornerie Thomas,Piessen Guillaume,El Hajbi Farid,Robb William B.,Clisant Stéphanie,Kramar Andrew,Mariette Christophe,Adenis Antoine
Funder
French Ministry of Health
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference18 articles.
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359–86.
2. Mariette C, Piessen G, Briez N, Gronnier C, Triboulet JP. Esophagogastric junction adenocarcinoma: which therapeutic approach ? Lancet Oncol. 2011;12:296–305.
3. Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681–92.
4. Shapiro J, van Lanschot JJ, Hulshof MC, van Hagen P, van Berge Henegouwen MI, Wijnhoven BP, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;5(15):40–6.
5. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;336:2074–84.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献